| Asthma |
0 |
0.86 |
| Thromboembolism |
0 |
0.64 |
| COVID-19 |
0 |
0.61 |
| Lung |
0 |
0.6 |
| Severe Asthma |
0 |
0.5 |
| ACE Inhibitor |
0 |
0.43 |
| Lung Cancer |
0 |
0.33 |
| Adolescent Medicine |
0 |
0.3 |
| Cancer |
0 |
0.3 |
| Emphysema |
0 |
0.3 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.3 |
| Receptors |
0 |
0.3 |
| Thrombosis |
0 |
0.3 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.24 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.24 |
| HIV Infection |
0 |
0.24 |
| Sarcoidosis |
0 |
0.24 |